Japan's Yanye Pharmaceutical Company announced on Friday (23rd) that it signed an agreement to import and sell in China with Chinese companies on the crown disease "XOCOVA".
According to the Kyodo News Agency, Yanye Yisi Pharmaceutical Company has submitted information to the relevant departments for the application for the listing of new drugs in China.Yano Yiyi will accelerate the expansion of overseas markets by taking advantage of the urgent approval in Japan.
Yan Yeyi and the joint venture company of Chinese enterprises signed an agreement with the subsidiary of the large pharmaceutical group "Shanghai Pharmaceutical".After being approved in China, the subsidiary will be exclusively responsible for importing Xocova to China and selling it to a medical wholesaler.
